FDA Considers Clinician-Style Testing for Generative AI Medical Devices
In one line: The FDA is reportedly exploring whether to assess generative AI medical devices like a human clinician rather than as static software.
Key points
- The FDA is said to be weighing evaluations that would have generative AI medical devices work through problems the way a clinician is examined.
- The driver is the nature of generative models: their outputs are not fixed and keep changing, which fits poorly with a one-time software clearance process.
- A "clinician-style" test implies probing an AI for the same judgment and reasoning expected of a practicing physician.
Why it matters
Healthcare is the most sensitive frontier of generative AI regulation. If the FDA formally moves this way, it could reshape how AI medical devices win approval — and set a reference point for other regulators and industries.